No connection

Search Results

IH vs PG

IH
iHuman Inc.
NEUTRAL
Price
$1.74
Market Cap
$88.9M
Sector
Consumer Defensive
AI Confidence
85%
PG
The Procter & Gamble Company
BEARISH
Price
$145.71
Market Cap
$340.49B
Sector
Consumer Defensive
AI Confidence
85%

Valuation

P/E Ratio
IH
6.69
PG
21.59
Forward P/E
IH
9.16
PG
20.23
P/B Ratio
IH
0.61
PG
6.48
P/S Ratio
IH
0.11
PG
3.99
EV/EBITDA
IH
-8.64
PG
14.76

Profitability

Gross Margin
IH
67.86%
PG
51.19%
Operating Margin
IH
4.72%
PG
26.3%
Profit Margin
IH
11.82%
PG
19.3%
ROE
IH
9.75%
PG
31.56%
ROA
IH
2.99%
PG
10.9%

Growth

Revenue Growth
IH
-18.1%
PG
1.5%
Earnings Growth
IH
-33.3%
PG
-5.4%

Financial Health

Debt/Equity
IH
0.01
PG
0.69
Current Ratio
IH
3.57
PG
0.72
Quick Ratio
IH
3.3
PG
0.47

Dividends

Dividend Yield
IH
--
PG
2.92%
Payout Ratio
IH
0.0%
PG
61.88%

AI Verdict

IH NEUTRAL

iHuman Inc. presents a classic deep-value paradox: it possesses a stable Piotroski F-Score of 6/9 and an exceptionally clean balance sheet, yet it is plagued by severe growth decay. While the stock trades at a significant discount to its Graham Number ($4.08) and book value (P/B 0.61), the negative YoY revenue (-18.10%) and earnings (-33.30%) growth suggest a value trap. The current price of $1.74 is slightly below the growth-based intrinsic value of $1.82, but the bearish technical trend and weak insider sentiment offset the valuation appeal.

Strengths
Extremely low valuation multiples (P/E 6.69, P/S 0.11)
Strong liquidity position with a Current Ratio of 3.57
Negligible leverage with a Debt/Equity ratio of 0.01
Risks
Significant revenue contraction (-18.10% YoY)
Sharp decline in earnings growth (-33.30% YoY)
Strongly bearish technical trend (0/100)
PG BEARISH

PG exhibits a stable financial foundation with a Piotroski F-Score of 6/9, but it is severely overvalued relative to its deterministic baselines. The current price of $145.71 represents a massive premium over the Graham Number ($58.45) and Intrinsic Value ($47.25), while a PEG ratio of 3.92 indicates the valuation is disconnected from its stagnant growth. Negative earnings growth (-5.40% YoY) combined with bearish insider activity and a 0/100 technical trend suggests significant downside risk despite the company's operational efficiency.

Strengths
Exceptional Return on Equity (ROE) of 31.56%
Strong gross margins (51.19%) and operating margins (26.30%)
Consistent track record of beating earnings estimates over 25 quarters
Risks
Extreme valuation premium over Graham and Intrinsic value estimates
Negative earnings growth (-5.40% YoY and -6.70% Q/Q)
Weak liquidity ratios with a Current Ratio of 0.72 and Quick Ratio of 0.47

Compare Another Pair

IH vs PG: Head-to-Head Comparison

This page compares iHuman Inc. (IH) and The Procter & Gamble Company (PG) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI Chat
Markets
Profile